De Burlo Group’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
De Burlo Group's SLXP Position: Q2 2015 in Review
De Burlo Group sold out of Salix Pharmaceuticals (SLXP) in Q2 2015, closing a stake of 3,100 shares — an estimated $535K sold.
De Burlo Group first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $12.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- De Burlo Group reported no remaining Salix Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- De Burlo Group sold 3,100 Salix Pharmaceuticals shares in Q2 2015, an estimated $535K.
- De Burlo Group first reported a position in Salix Pharmaceuticals in Q1 2014 and held it in 5 quarters.
- De Burlo Group's Salix Pharmaceuticals position peaked at $12.8M in Q3 2014.
- 1 fund tracked by Wall St. Rank held Salix Pharmaceuticals as of Q2 2015.
Based on De Burlo Group's 13F filing for Q2 2015, filed 7 Aug 2015.